메뉴 건너뛰기




Volumn 33, Issue 4, 2012, Pages 173-175

The antiphospholipid syndrome in 2012: Its heterogeneity requires a personalized care;Le syndrome des antiphospholipides en 2012 : Son hétérogénéité impose une prise en charge personnalisée

Author keywords

Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; HUMAN; PATIENT CARE; PERSONALIZED MEDICINE;

EID: 84858737942     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.01.010     Document Type: Article
Times cited : (4)

References (20)
  • 1
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
    • (2006) J Thromb Haemost , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3    Branch, D.W.4    Brey, R.L.5    Cervera, R.6
  • 2
    • 84858754201 scopus 로고    scopus 로고
    • Manifestations dermatologiques du syndrome des antiphospholipides
    • Frances C, Barete S, Soria A. Manifestations dermatologiques du syndrome des antiphospholipides. Rev Med Interne 2011 []. http://dx.doi.org/10.1016/j.revmed.2011.10.003.
    • (2011) Rev Med Interne.
    • Frances, C.1    Barete, S.2    Soria, A.3
  • 3
    • 20744443648 scopus 로고    scopus 로고
    • Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases
    • Frances C., Niang S., Laffitte E., Pelletier F., Costedoat N., Piette J.C. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 2005, 52:1785-1793.
    • (2005) Arthritis Rheum , vol.52 , pp. 1785-1793
    • Frances, C.1    Niang, S.2    Laffitte, E.3    Pelletier, F.4    Costedoat, N.5    Piette, J.C.6
  • 4
    • 81955163000 scopus 로고    scopus 로고
    • Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies
    • Reiner P., Galanaud D., Leroux G., Vidailhet M., Haroche J., Huong du L.T., et al. Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies. Mov Disord 2011, 26:2422-2427.
    • (2011) Mov Disord , vol.26 , pp. 2422-2427
    • Reiner, P.1    Galanaud, D.2    Leroux, G.3    Vidailhet, M.4    Haroche, J.5    Huong du, L.T.6
  • 5
    • 0034924140 scopus 로고    scopus 로고
    • International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium
    • Wilson W.A., Gharavi A.E., Piette J.C. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus 2001, 10:457-460.
    • (2001) Lupus , vol.10 , pp. 457-460
    • Wilson, W.A.1    Gharavi, A.E.2    Piette, J.C.3
  • 7
    • 4043055247 scopus 로고    scopus 로고
    • Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome
    • Tektonidou M.G., Sotsiou F., Nakopoulou L., Vlachoyiannopoulos P.G., Moutsopoulos H.M. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 2004, 50:2569-2579.
    • (2004) Arthritis Rheum , vol.50 , pp. 2569-2579
    • Tektonidou, M.G.1    Sotsiou, F.2    Nakopoulou, L.3    Vlachoyiannopoulos, P.G.4    Moutsopoulos, H.M.5
  • 9
    • 84858750617 scopus 로고    scopus 로고
    • Anticorps antiphospholipides et hémostase
    • Masliah-Planchon J, Darnige L. Anticorps antiphospholipides et hémostase. Rev Med Interne 2011 []. http://dx.doi.org/10.1016/j.revmed.2011.10.008.
    • (2011) Rev Med Interne.
    • Masliah-Planchon, J.1    Darnige, L.2
  • 10
    • 79953305113 scopus 로고    scopus 로고
    • Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
    • Ruiz-Irastorza G., Cuadrado M.J., Ruiz-Arruza I., Brey R., Crowther M., Derksen R., et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 2011, 20:206-218.
    • (2011) Lupus , vol.20 , pp. 206-218
    • Ruiz-Irastorza, G.1    Cuadrado, M.J.2    Ruiz-Arruza, I.3    Brey, R.4    Crowther, M.5    Derksen, R.6
  • 12
    • 79960408773 scopus 로고    scopus 로고
    • Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies
    • Zuily S., Regnault V., Selton-Suty C., Eschwege V., Bruntz J.F., Bode-Dotto E., et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation 2011, 124:215-224.
    • (2011) Circulation , vol.124 , pp. 215-224
    • Zuily, S.1    Regnault, V.2    Selton-Suty, C.3    Eschwege, V.4    Bruntz, J.F.5    Bode-Dotto, E.6
  • 13
    • 70449390005 scopus 로고    scopus 로고
    • The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
    • de Laat B., Pengo V., Pabinger I., Musial J., Voskuyl A.E., Bultink I.E., et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009, 7:1767-1773.
    • (2009) J Thromb Haemost , vol.7 , pp. 1767-1773
    • de Laat, B.1    Pengo, V.2    Pabinger, I.3    Musial, J.4    Voskuyl, A.E.5    Bultink, I.E.6
  • 14
    • 33644865455 scopus 로고    scopus 로고
    • The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome
    • Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., Duhaut P., Costedoat N., Andreu M.R., et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 2006, 45:332-338.
    • (2006) Rheumatology (Oxford) , vol.45 , pp. 332-338
    • Le Thi Huong, D.1    Wechsler, B.2    Vauthier-Brouzes, D.3    Duhaut, P.4    Costedoat, N.5    Andreu, M.R.6
  • 15
    • 67349205869 scopus 로고    scopus 로고
    • Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the " CAPS Registry"
    • Cervera R., Bucciarelli S., Plasin M.A., Gomez-Puerta J.A., Plaza J., Pons-Estel G., et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the " CAPS Registry" J Autoimmun 2009, 32:240-245.
    • (2009) J Autoimmun , vol.32 , pp. 240-245
    • Cervera, R.1    Bucciarelli, S.2    Plasin, M.A.3    Gomez-Puerta, J.A.4    Plaza, J.5    Pons-Estel, G.6
  • 16
    • 84858710698 scopus 로고    scopus 로고
    • High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'
    • Pengo V., Ruiz-Irastorza G., Denas G., Andreoli L., Khamashta M., Tincani A. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'. Autoimmun Rev 2011, [http://dx.doi.org/10.1016/j.bbr.2011.03.031].
    • (2011) Autoimmun Rev
    • Pengo, V.1    Ruiz-Irastorza, G.2    Denas, G.3    Andreoli, L.4    Khamashta, M.5    Tincani, A.6
  • 17
    • 44949233631 scopus 로고    scopus 로고
    • The potential for interaction between warfarin and coprescribed medication: a retrospective study in primary care
    • Snaith A., Pugh L., Simpson C.R., McLay J.S. The potential for interaction between warfarin and coprescribed medication: a retrospective study in primary care. Am J Cardiovasc Drugs 2008, 8:207-212.
    • (2008) Am J Cardiovasc Drugs , vol.8 , pp. 207-212
    • Snaith, A.1    Pugh, L.2    Simpson, C.R.3    McLay, J.S.4
  • 18
    • 84857995541 scopus 로고    scopus 로고
    • High-risk antimicrobial prescriptions among ambulatory patients on warfarin
    • [Epub ahead of print]
    • Lane M.A., Devine S.T., McDonald J.R. High-risk antimicrobial prescriptions among ambulatory patients on warfarin. J Clin Pharm Ther 2011, [Epub ahead of print]. 10.1111/j.1365-2710.2011.01270.x.
    • (2011) J Clin Pharm Ther
    • Lane, M.A.1    Devine, S.T.2    McDonald, J.R.3
  • 20
    • 77951220413 scopus 로고    scopus 로고
    • Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?
    • Cohen H., Machin S.J. Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?. Lupus 2010, 19:486-491.
    • (2010) Lupus , vol.19 , pp. 486-491
    • Cohen, H.1    Machin, S.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.